Clinical Trials Browser

Phase 2 × Multiple Myeloma × Taxes × Clear all

NCT01646762 2017-10-16

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Terminated

13 enrolled 11 charts

Multiple Myeloma